Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon May 14, 2021 6:14pm
69 Views
Post# 33208550

RE:Q1 is of no interest, what happens next week$ is.

RE:Q1 is of no interest, what happens next week$ is.

They have no money!! And partnership have been tried forever so they will sell division or shot it down. And how much money did they burn in Q1? Another $26M similar to Q4? That would leave $20M at beginning of April.... hmmmmm that's not a lot of cash for Pritchard and Sartores salaries for accomplishing absolutely nothing, wouldn't you say? 


realstocky wrote:

We all know they made no money, and that there is no partnership struck...yet.

 


 



<< Previous
Bullboard Posts
Next >>